Document is current
Any future updates will be listed below
-
Authors
Wong, Felix https://orcid.org/0000-0002-2309-8835
Zheng, Erica J.
Valeri, Jacqueline A. https://orcid.org/0000-0002-3430-5924
Donghia, Nina M.
Anahtar, Melis N.
Omori, Satotaka
Li, Alicia
Cubillos-Ruiz, Andres
Krishnan, Aarti https://orcid.org/0000-0002-7936-4442
Jin, Wengong https://orcid.org/0000-0002-0555-3056
Manson, Abigail L. https://orcid.org/0000-0002-3800-0714
Friedrichs, Jens https://orcid.org/0000-0002-7166-6120
Helbig, Ralf https://orcid.org/0000-0002-8326-9499
Hajian, Behnoush
Fiejtek, Dawid K.
Wagner, Florence F.
Soutter, Holly H.
Earl, Ashlee M. https://orcid.org/0000-0001-7857-9145
Stokes, Jonathan M.
Renner, Lars D. https://orcid.org/0000-0003-0178-1788
Collins, James J. https://orcid.org/0000-0002-5560-8246
- License Information
-
More Information
Article History
Received: 5 January 2022
Accepted: 21 November 2023
First Online: 20 December 2023
Competing interests
: J.J.C. is an academic co-founder and scientific advisory board chair of EnBiotix, an antibiotic drug discovery company, and Phare Bio, a non-profit venture focused on antibiotic drug development. J.J.C. is also an academic co-founder and board member of Cellarity and the founding scientific advisory board chair of Integrated Biosciences. J.M.S. is scientific co-founder and scientific director of Phare Bio. F.W. is a co-founder of Integrated Biosciences. S.O. and A.L. contributed to this work as employees of Integrated Biosciences, and S.O. may have an equity interest in Integrated Biosciences. F.W. and J.J.C. have filed a patent based on the results of this work. The remaining authors declare no competing interests.
